Baixar PDF

Outros usuários também visualizaram estes artigos

Oligosymptomatic infection by SARS-Cov-2 in catastrophic antiphospholipid syndrome, a singular coincidence: a case report in an Ecuadorian hospital Jorge Luis Vélez-Páez; Jhonny Manuel Carranza-Jara; Doryz Catalina Almeida-Posso; Steven S. Witkin; Cesar de Almeida-Neto;
Hematol Transfus Cell Ther. 2024;46:316-20
Proportion of hematological cancer patients with SARS-CoV-2 infection during the COVID-19 pandemic: A systematic review and meta-analysis Mohammadali Jafari; Seyed Alireza Dastgheib; Farzad Ferdosian; Hamid Mirjalili; Hossein Aarafi; Mahmood Noorishadkam; Mahta Mazaheri; Hossein Neamatzadeh;
Hematol Transfus Cell Ther. 2022;44:225-34
Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular Consensus on genetically modified cells. I: Structuring centers for the multidisciplinary clinical administration and management of CAR-T cell therapy patients Diego V. Clé; Alexandre V. Hirayama; Alvaro J. Alencar; Luciano J. Costa; João V.P. Feliciano; Ederson R. Mattos; Ana C. Cordeiro; Marco Aurélio Salvino; George M. Navarro Barros; Marcos de Lima; Phillip Scheinberg; Renato L. Guerino-Cunha;
Hematol Transfus Cell Ther. 2021;43 Supl 2:S3-S12